Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase II randomized double-blind multicenter trial of Huangkui granules in children with Henoch-Schönlein purpura nephritis
CTR20230013Phase 2Active
- Sponsor
- Suzhong Pharmaceutical Group
- Start
- Mar 2023
- Countries
- 1
01
Overview
A Phase 2 trial of huang kui capsule in IgA vasculitis nephritis, sponsored by Suzhong Pharmaceutical Group. Started Mar 2023; status: active.
02
Drugs
huang kui capsule
03
Conditions
IgA vasculitis nephritis
Beyond the preview
Go deeper on CTR20230013.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20230013.